|
| Press Releases |
|
 |
|
| Thursday, March 20, 2025 |
|
|
Venturi Partners Launches $225 Million Second Fund to Fuel Disruptive Consumer Brands in Southeast Asia and India |
| Venturi Partners, a Singapore based leading growth-stage consumer-focused investor in India and Southeast Asia, has announced the launch of its second fund, targeting $225 million, with a hard cap of $250 million. more info >> |
|
| Tuesday, February 11, 2025 |
|
|
Venturi Partners invests USD 25M in footwear brand JQR |
| Venturi Partners, a leading consumer fund in India and Southeast Asia, today announced a $25 million investment in JQR (Just Quick Run), a rapidly emerging brand in the affordable footwear segment. more info >> |
|
| Tuesday, March 26, 2024 |
|
|
Venturi Partners invests $25 million in DALI Discount, Philippines' leading chain of discount grocery stores |
| Venturi Partners, a prominent growth equity firm specialising in consumer investments across India and Southeast Asia, today announced its recent investment in DALI Discount, a rapidly expanding hard discount chain operating in the Philippines. more info >> |
|
| Wednesday, April 27, 2022 |
|
|
Venturi Partners ปิดตลาดครั้งสุดท้ายที่ 175 ล้านเหรียญสหรัฐ ในกองทุนเปิดใหม่ |
| Venturi Partners แพลตฟอร์มการลงทุนในสิงคโปร์ที่ส่งเสริมแบรนด์ชั้นนำในอินเดียและเอเชียตะวันออกเฉียงใต้ ประกาศในวันนี้ว่ากองทุนหลักของบริษัทได้บรรลุเป้าที่ 175 ล้านเหรียญสหรัฐ อีกทั้งบริษัทอาจเพิ่มขนาดของกองทุนจากเดิมเพื่อรองรับความต้องการลงทุนเพิ่มขึ้น more info >> |
|
|
Venturi Partners mencapai penutupan akhir dana perdana sebesar USD 175 juta |
| Venturi Partners, platform investasi berbasis di Singapura yang mendukung merek-merek berani di India dan Asia Tenggara, hari ini mengatakan bahwa dana pertamanya, yang mengumpulkan USD 175 juta, telah mencapai penutupan akhir. more info >> |
|
| Tuesday, April 26, 2022 |
|
|
Venturi Partners Hits Final Close of USD 175M in Maiden Fund |
| Venturi Partners, a Singapore-based investment platform that empowers audacious brands in India and Southeast Asia, announced today that its maiden fund has hit its final close of USD 175 million. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
維昇藥業(2561.HK)維臻高(R)獲批:重長效生長激素王者登場 重構百億市場的商業天花板
Feb 25, 2026 14:58 HKT/SGT
|
|
|
Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026
Feb 25, 2026 14:54 HKT/SGT
|
|
|
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
Feb 25, 2026 12:46 HKT/SGT
|
|
|
ベイシアのスーパーマーケット内の冷蔵・冷凍庫の温度点検・記録業務を富士通のIoT可視化ソリューションにより自動化
Feb 25, 2026 12:00: JST
|
|
|
Beisia Automates Supermarket Refrigerator Temperature Monitoring and Recording with Fujitsu's IoT Visualization Solution
Feb 25, 2026 12:00 JST
|
|
|
國泰君安國際獲批使用SIMM 衍生品風險管理接軌國際標準
Feb 25, 2026 10:34 HKT/SGT
|
|
|
国泰君安国际获批使用SIMM 衍生品风险管理接轨国际标准
Feb 25, 2026 10:34 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 22:30: JST
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT/SGT
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2026 That Represent All the Participants in the Event with Woven Lines
Feb 24, 2026 22:00 JST
|
|
|
康哲藥業(867.HK/8A8.SG):創新藥磷酸蘆可替尼乳膏增加特應性皮炎(AD)適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT/SGT
|
|
|
康哲药业(867.HK/8A8.SG):创新药磷酸芦可替尼乳膏增加特应性皮炎(AD)适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Ships First Units of Systems for Marine Ammonia-Fueled Engines
Feb 24, 2026 20:07 JST
|
|
|
MHI Unveils "DIAVAULT," a Secure, High Performance Edge Data Center Platform
Feb 24, 2026 19:55 JST
|
|
|
康希諾生物曼海欣(R)擴齡正式獲批 為公司長期價值開啟更廣闊發展空間
Feb 24, 2026 18:15 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|